Combined with the ACD, TSC1, and FLCN mutations uncovered in the previous search focusing on known susceptibility genes to CMM or RCC, potential candidate(s) were identified in 34 of 46 cases (74%; Table S1). This evidence concerns the gene FLCN and renal cell carcinoma.